General Biotechnology

The Authorized Generic Playbook: Why Brands Launch Their Own Competition, Even if There is No Competition

Why Big Pharma’s Secret Weapon Is Sometimes Their Own Worst Enemy
Imagine a world where the very companies that develop groundbreaking medicines also launch their own “competition” — not because they want to, but because they have to. It sounds counter…

The Authorized Generic Playbook: Why Brands Launch Their Own Competition, Even if There is No Competition Read Post »

General Biotechnology

Pick the Right FDA Pathway and You Own the Market. Pick the Wrong One and You’re Funding Your Competitor.

In the fiercely competitive landscape of pharmaceutical innovation, timing and strategic navigation through regulatory pathways can make or break a company’s market dominance. Yet, many biotech and pharma firms underestimate the critical importance of …

Pick the Right FDA Pathway and You Own the Market. Pick the Wrong One and You’re Funding Your Competitor. Read Post »

Biotechblog
Scroll to Top